Study of the Efficacy and Safety of SCH 486757 in Subjects With Chronic Cough (Study P04887)
Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, placebo-controlled, crossover, single center study of SCH
486757 in subjects with chronic cough. Subjects will be randomized to receive SCH 486757 or
placebo for 14 days. After a 2-week washout period, subjects will be crossed over to the
other treatment. The primary objective is to evaluate the effectiveness of SCH 486757 in
reducing cough reflex sensitivity as determined by a challenge with capsaicin, an agent that
induces cough.